| http://www.w3.org/ns/prov#value | - Team leader Kim Kun-hong of Yonsei University told the Korea Times the discovery that enzyme protein kinase CK2 makes cancer cells resistant to cancer-specific therapeutic chemicals, such as Trail, is a step toward developing effective treatments for the disease.
|
